Travere Therapeutics Inc (TVTX) — Working Capital to Net Assets Ratio
Travere Therapeutics Inc (TVTX) has a Working Capital to Net Assets ratio of 270.7% as of March 2026. Working capital of $267.24 Million (current assets of $392.68 Million minus current liabilities of $125.44 Million) is measured against net assets of $98.73 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See defensive interval ratio of Travere Therapeutics Inc to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Travere Therapeutics Inc Working Capital to Net Assets (2010–2025)
This chart shows how Travere Therapeutics Inc's Working Capital to Net Assets ratio has evolved across 16 annual periods from 2010 to 2025. As of March 2026, the ratio stands at 270.7%, reflecting working capital of $267.24 Million against net assets of $98.73 Million USD. For the complete balance sheet picture, see Travere Therapeutics Inc total assets.
Annual Working Capital to Net Assets for Travere Therapeutics Inc (2010–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Travere Therapeutics Inc from 2010 to 2025, covering 16 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check financial resilience of Travere Therapeutics Inc to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 241.8% | $277.66 Million | $114.83 Million | $437.56 Million | $159.90 Million | ▼ -123.7 pp |
| 2024 | 365.5% | $215.95 Million | $59.08 Million | $416.70 Million | $200.75 Million | ▲ +147.0 pp |
| 2023 | 218.5% | $438.87 Million | $200.81 Million | $616.77 Million | $177.91 Million | ▼ -584.9 pp |
| 2022 | 803.4% | $344.27 Million | $42.85 Million | $486.44 Million | $142.16 Million | ▲ +651.6 pp |
| 2021 | 151.8% | $458.74 Million | $302.11 Million | $582.83 Million | $124.09 Million | ▲ +1.4 pp |
| 2020 | 150.4% | $317.75 Million | $211.21 Million | $410.41 Million | $92.66 Million | ▼ -0.4 pp |
| 2019 | 150.8% | $333.62 Million | $221.20 Million | $429.06 Million | $95.45 Million | ▲ +27.9 pp |
| 2018 | 122.9% | $391.06 Million | $318.25 Million | $495.68 Million | $104.62 Million | ▲ +41.0 pp |
| 2017 | 81.9% | $240.14 Million | $293.13 Million | $325.81 Million | $85.67 Million | ▲ +1.0 pp |
| 2016 | 80.9% | $249.09 Million | $307.77 Million | $332.35 Million | $83.26 Million | ▲ +8.9 pp |
| 2015 | 72.1% | $216.13 Million | $299.97 Million | $301.93 Million | $85.80 Million | ▼ -116.4 pp |
| 2014 | 188.5% | $-70.20 Million | $-37.25 Million | $37.33 Million | $107.54 Million | ▲ +37.2 pp |
| 2013 | 151.3% | $-27.71 Million | $-18.31 Million | $7.50 Million | $35.21 Million | ▼ -17.9 pp |
| 2012 | 169.2% | $-5.77 Million | $-3.41 Million | $33.22K | $5.80 Million | ▲ +69.2 pp |
| 2011 | 100.0% | $-63.08K | $-63.08K | $3.91K | $66.99K | ▲ +0.0 pp |
| 2010 | 100.0% | $-60.26K | $-60.26K | $3.96K | $64.21K | — |